These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3671387)

  • 1. Inhibition of platelet 5-HT secretion and of 5-HT induced vasoconstriction by paracetamol.
    Verheggen R; Schrör K
    Prog Clin Biol Res; 1987; 242():271-6. PubMed ID: 3671387
    [No Abstract]   [Full Text] [Related]  

  • 2. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
    Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of aspirin and paracetamol on the aggregation of equine blood platelets.
    Heath MF; Evans RJ; Poole AW; Hayes LJ; McEvoy RJ; Littler RM
    J Vet Pharmacol Ther; 1994 Oct; 17(5):374-8. PubMed ID: 7853463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects.
    Rao AK; Willis J; Holmsen H
    J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
    Viisoreanu D; Gear A
    Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
    Carter AJ; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
    Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
    Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses.
    Menzies-Gow NJ; Sepulveda MF; Bailey SR; Cunningham FM; Elliott J
    Am J Vet Res; 2008 Feb; 69(2):199-207. PubMed ID: 18241016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators.
    MacIntyre DE; Bushfield M; MacMillan LJ; Moffat KJ; Murdoch FA; Thomson A; Rossi AG; McNicol A
    Agents Actions Suppl; 1986; 20():45-62. PubMed ID: 3028106
    [No Abstract]   [Full Text] [Related]  

  • 11. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets.
    Bailey SR; Andrews MJ; Elliott J; Cunningham F
    Res Vet Sci; 2000 Apr; 68(2):175-80. PubMed ID: 10756136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquisition and aggregation of canine blood platelets: basic mechanisms of function and differences because of breed origin.
    Clemmons RM; Meyers KM
    Am J Vet Res; 1984 Jan; 45(1):137-44. PubMed ID: 6422804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets, eicosanoids, and coronary vasospasm.
    Schrör K; Verheggen R
    Prog Clin Biol Res; 1987; 242():165-70. PubMed ID: 3118379
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitory effects of copper-aspirin complex on platelet aggregation.
    Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
    Pilo R; Aharony D; Raz A
    Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biochemical mechanisms of shear-induced platelet aggregation.
    Hardwick RA; Gritsman HN; Stromberg RR; Friedman LI
    Trans Am Soc Artif Intern Organs; 1983; 29():448-53. PubMed ID: 6673266
    [No Abstract]   [Full Text] [Related]  

  • 17. Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein.
    Simpson RM; Prancan A; Izzi JM; Fiedel BA
    Immunology; 1982 Sep; 47(1):193-202. PubMed ID: 7118160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antiaggregant activity of paracetamol and derivatives.
    Dupin JP; Gravier D; Casadebaig F; Boisseau MR; Bernard H
    Thromb Res; 1988 May; 50(3):437-47. PubMed ID: 3134743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet pro-aggregatory effects of CD40L monoclonal antibody.
    Mirabet M; Barrabés JA; Quiroga A; Garcia-Dorado D
    Mol Immunol; 2008 Feb; 45(4):937-44. PubMed ID: 17959249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.